LEO 29102 Cream in the Treatment of Atopic Dermatitis
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
This is a proof of concept and dose finding Phase II trial comparing 5 dose strengths with
vehicle and an active comparator (Elidel cream 10 mg/g) in a 4 week, twice daily treatment
regimen in mild to moderate atopic dermatitis patients.